This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stamper, P. D.
Right arrow Articles by Carroll, K. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stamper, P. D.
Right arrow Articles by Carroll, K. C.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2009, p. 373-378, Vol. 47, No. 2
0095-1137/09/$08.00+0     doi:10.1128/JCM.01613-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Comparison of a Commercial Real-Time PCR Assay for tcdB Detection to a Cell Culture Cytotoxicity Assay and Toxigenic Culture for Direct Detection of Toxin-Producing Clostridium difficile in Clinical Samples{triangledown}

Paul D. Stamper,1 Romina Alcabasa,2 Deborah Aird,2 Wisal Babiker,2 Jennifer Wehrlin,2 Ijeoma Ikpeama,2 and Karen C. Carroll1,2*

Division of Medical Microbiology, Department of Pathology, The Johns Hopkins University School of Medicine,1 The Johns Hopkins Hospital Microbiology Laboratory, Baltimore, Maryland2

Received 19 August 2008/ Returned for modification 23 September 2008/ Accepted 2 December 2008

Rapid detection of toxin-producing strains of Clostridium difficile is essential for optimal management of patients with C. difficile infection. The BD GeneOhm (San Diego, CA) Cdiff assay, a real-time PCR assay that amplifies tcdB, was compared to a cell culture neutralization assay (Wampole C. difficile Toxin B [TOX-B] test; TechLab, Blacksburg, VA) and to toxigenic culture. Using liquid (n = 273) and soft (n = 131) stool specimens from 377 symptomatic patients, all testing was performed on the same day by independent laboratory staff according to the manufacturers' protocols. Toxigenic bacterial culture was performed as follows. A 0.5-ml aliquot of stool was heated to 80°C for 10 min, followed by inoculation onto modified cycloserine cefoxitin fructose agar with and without horse blood (Remel, Lenexa, KS) and into prereduced chopped-meat broth. Of the 404 stool specimens tested, 340 were negative and 40 were positive (10.0% prevalence) both by PCR for tcdB and by cytotoxin production. The overall agreement between the BD GeneOhm Cdiff assay and the TOX-B test was 94.8% (380/401). When the TOX-B test was used as the reference method, the initial sensitivity, specificity, and positive and negative predictive values of the BD GeneOhm Cdiff assay were 90.9% (40/44), 95.2% (340/357), 70.2% (40/57), and 98.8% (340/344), respectively. When toxigenic culture was used as the "gold standard," the sensitivity, specificity, and positive and negative predictive values of the BD GeneOhm Cdiff assay were 83.6%, 98.2%, 89.5%, and 97.1%, respectively, and those of the TOX-B test were 67.2%, 99.1%, 93.2%, and 94.4%, respectively. PCRs for three samples were inhibited upon initial testing; one sample was resolved upon retesting. One sample produced nonspecific cytotoxin results. The BD GeneOhm Cdiff assay performed well compared to a standard cell culture neutralization assay and to toxigenic culture for the detection of toxigenic C. difficile directly from fecal specimens.


* Corresponding author. Mailing address: The Johns Hopkins Medical Institutions, Division of Medical Microbiology, Meyer B1-193, 600 N. Wolfe St., Baltimore, MD 21287. Phone: (410) 955-5077. Fax: (410) 614-8087. E-mail: kcarrol7{at}jhmi.edu

{triangledown} Published ahead of print on 10 December 2008.


Journal of Clinical Microbiology, February 2009, p. 373-378, Vol. 47, No. 2
0095-1137/09/$08.00+0     doi:10.1128/JCM.01613-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Huang, H., Weintraub, A., Fang, H., Nord, C. E. (2009). Comparison of a Commercial Multiplex Real-Time PCR to the Cell Cytotoxicity Neutralization Assay for Diagnosis of Clostridium difficile Infections. J. Clin. Microbiol. 47: 3729-3731 [Abstract] [Full Text]  
  • Terhes, G., Urban, E., Soki, J., Nacsa, E., Nagy, E. (2009). Comparison of a Rapid Molecular Method, the BD GeneOhm Cdiff Assay, to the Most Frequently Used Laboratory Tests for Detection of Toxin-Producing Clostridium difficile in Diarrheal Feces. J. Clin. Microbiol. 47: 3478-3481 [Abstract] [Full Text]  
  • Eastwood, K., Else, P., Charlett, A., Wilcox, M. (2009). Comparison of Nine Commercially Available Clostridium difficile Toxin Detection Assays, a Real-Time PCR Assay for C. difficile tcdB, and a Glutamate Dehydrogenase Detection Assay to Cytotoxin Testing and Cytotoxigenic Culture Methods. J. Clin. Microbiol. 47: 3211-3217 [Abstract] [Full Text]  
  • Peterson, L. R., Robicsek, A. (2009). Does My Patient Have Clostridium difficile Infection?. ANN INTERN MED 151: 176-179 [Abstract] [Full Text]  
  • Wroblewski, D., Hannett, G. E., Bopp, D. J., Dumyati, G. K., Halse, T. A., Dumas, N. B., Musser, K. A. (2009). Rapid Molecular Characterization of Clostridium difficile and Assessment of Populations of C. difficile in Stool Specimens. J. Clin. Microbiol. 47: 2142-2148 [Abstract] [Full Text]  
  • Barbut, F., Braun, M., Burghoffer, B., Lalande, V., Eckert, C. (2009). Rapid Detection of Toxigenic Strains of Clostridium difficile in Diarrheal Stools by Real-Time PCR. J. Clin. Microbiol. 47: 1276-1277 [Full Text]  
  • Kelly, C. P. (2009). A 76-Year-Old Man With Recurrent Clostridium difficile-Associated Diarrhea: Review of C difficile Infection. JAMA 301: 954-962 [Abstract] [Full Text]